Related Experiment Video
Updated: Jun 19, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Fospropofol: a new sedative-hypnotic agent for monitored anesthesia care
Gina D Moore1, Alyssa M Walker, Robert MacLaren
1School of Pharmacy, University of Colorado Denver, 12631 E. 17th Ave., Mail Stop C238-L15, Aurora, CO 80045, USA. gina.moore@ucdenver.edu
Fospropofol offers advantages over propofol for procedural sedation by reducing adverse effects and improving recovery. However, limited safety data necessitates careful administration by anesthesia professionals.
Area of Science:
- Pharmacology
- Anesthesiology
- Drug Development
Background:
- Propofol, a sedative-hypnotic, has limitations including pain on injection and potential for deep sedation.
- Fospropofol is a water-soluble prodrug designed to overcome propofol's lipid emulsion-associated disadvantages.
Purpose of the Study:
- To review clinical data on fospropofol's safety and efficacy.
- To provide information for formulary review of fospropofol.
- To critically assess fospropofol as a sedative-hypnotic agent.
Main Methods:
- Searched MEDLINE, EMBASE, bibliographies, and FDA databases (up to June 2009).
- Included key terms: fospropofol, Lusedra, Aquavan, sedative-hypnotic, monitored anesthesia care.
- Reviewed all Phase 1, 2, and 3 clinical trials on fospropofol safety and efficacy.
Main Results:
- Fospropofol offers a more predictable onset and gradual recovery compared to propofol.
- Limited patient numbers and safety data exist, with reported hypoxemia and hypotension.
- FDA approval is restricted to monitored anesthesia care for diagnostic/therapeutic procedures.
Conclusions:
- Fospropofol is a promising sedative-hypnotic agent, minimizing propofol's adverse effects.
- Its pharmacokinetic profile supports sedation, anxiolysis, and rapid recovery.
- Limited safety data warrant use only with dedicated anesthesia personnel.
Related Concept Videos
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Inhalational Anesthetics: Overview